Gossamer Bio, Inc. / Fundamentals
Income statement
- Net revenue
€34.67M - Cost of goods sold
€0.00 - Gross profit
€34.67M - SG&A expenses
€30.36M - R&D expenses
€129.77M - EBITDA
-€110.79M - D&A
€2.35M - EBIT
-€125.46M - Interest expenses
€9.44M - EBT
-€122.59M - Tax expenses
-€3.05M - Net income
-€119.53M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€23.58M - Changes in working capital
-€47.05M - Operating cash flow
-€132.94M - Capex
-€100.17M - Other investing cash flow
-€100.24M - Net investing cash flow
€79.82M - Total cash dividends paid
€0.00 - Issuance of common stock
-€699.58K - Debt repayment
€0.00 - Other financing cash flow
€436.81K - Net financing cash flow
€757.30K - Foreign exchange effects
€174.03K - Net change in cash
-€52.18M - Cash at end of period
€22.67M - Free cash flow
-€233.11M
Balance sheet
- Cash and cash equivalents
€22.67M - Cash and short-term investments
€183.44M - Total receivables
€6.87M - Inventory
€0.00 - Other current assets
€12.92M - Total current assets
€203.24M - Property, plant & equipment
€4.00M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€329.97K - Total non-current assets
€4.33M - Total assets
€207.57M - Accounts payable
€1.62M - Short-term debt
€1.53M - Other current liabilities
€23.57M - Total current liabilities
€46.17M - Long-term debt
€173.98M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€201.12M - Total liabilities
€247.29M - Common stock
€19.82K - Retained earnings
-€1.16B - Other equity
-€4.38M - Total equity
-€39.72M - Total liabilities and shareholders' equity
€207.57M
Company information
- Market capitalization
€242.35M - Employees
144 - Enterprise Value
€466.13M
Company ratios
- Gross margin
-
100.0% Much better than peer group: -2,970.7% - EBITDA margin
-
-319.6% Much better than peer group: -30,827.5% - EBIT margin
-
-361.9% Much better than peer group: -31,737.1% - EBT margin
-
-353.6% Much better than peer group: -29,348.8% - Net margin
-
-344.8% Much better than peer group: -29,307.8% - ROE
-
300.9% Much better than peer group: -105.0% - ROA
-
-57.6% Worse than peer group: -43.7% - Asset turnover
-
16.7% Better than peer group: 4.4% - FCF margin
-
-94.5% Much better than peer group: -23,832.1% - FCF yield
-13.5% - Efficiency ratio
419.6% - Net sales per employee
-
€240.74K - Net income per employee
-
-€830.10K